Document Detail


Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood.
MedLine Citation:
PMID:  15517570     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Experiments described herein were designed to evaluate the performance characteristics of a flow cytometry-based system that scores the incidence of peripheral blood micronucleated reticulocytes (MN-RETs). These procedures represent the continued refinement of a previously reported anti-CD71-based method (Dertinger et al. [1996]: Mutat Res 371:283-292), with the following modifications: incorporation of a third fluorescent label to exclude platelets from the MN-RET region, and use of a CD71-associated fluorescence thresholding technique to increase data acquisition rates. Mouse, rat, and human blood samples were analyzed using both the previously described two-color procedure (anti-CD71-FITC and propidium iodide) and a newly developed three-color technique (which adds an antiplatelet-PE antibody). The rodent specimens were also evaluated by standard microscopy procedures (acridine orange staining). Mouse blood was collected via heart puncture of vehicle- and 5-fluorouracil-treated CD-1 mice; blood samples from saline-treated Sprague-Dawley rats were collected from the tail vein and via heart puncture. Rodent blood samples were analyzed by both the two- and three-color methods. Human blood specimens, obtained via arm venipuncture from cancer patients undergoing radiation therapy, were analyzed for MN-RETs using the two-color method. Subsequently, blood samples from a single chemotherapy patient were analyzed by both the two- and three-color methods. Finally, the chemotherapy patient blood samples and blood samples from 15 healthy volunteers were evaluated at very high densities in conjunction with a CD71-associated fluorescence thresholding technique. Results of these investigations showed that data from mouse blood analyzed by the two- and three-color procedures correlated well with microscopy data (r values = 0.917 and 0.937 for the two- and three-color methods, respectively); all three methods confirmed the genotoxicity of 5-FU. Data from rat tail vein samples showed improved reproducibility with the three-color technique, but no significant difference between the two techniques was seen with the heart puncture specimens. Human blood analyzed according to the two-color procedure produced unreliable results, as platelets and platelet aggregates impacted the rare MN-RET scoring region. The three-color technique effectively overcame this problem and produced reproducible measurements that fell within expected ranges. For human blood analyses, the high cell density/CD71-thresholding technique provided significant improvements over the low-density technique, as it allowed data acquisition to occur approximately six times faster with no loss of sensitivity.
Authors:
Stephen D Dertinger; Kevin Camphausen; James T Macgregor; Michelle E Bishop; Dorothea K Torous; Svetlana Avlasevich; Siân Cairns; Carol R Tometsko; Cynthia Menard; Thierry Muanza; Yuhchyau Chen; Richard K Miller; Karin Cederbrant; Kerstin Sandelin; Ingrid Pontén; George Bolcsfoldi
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Environmental and molecular mutagenesis     Volume:  44     ISSN:  0893-6692     ISO Abbreviation:  Environ. Mol. Mutagen.     Publication Date:  2004  
Date Detail:
Created Date:  2004-12-14     Completed Date:  2005-03-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8800109     Medline TA:  Environ Mol Mutagen     Country:  United States    
Other Details:
Languages:  eng     Pagination:  427-35     Citation Subset:  IM    
Affiliation:
Litron Laboratories, Rochester, New York 14620, USA. sdertinger@litronlabs.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Antigens, CD / immunology,  metabolism
Antigens, Differentiation, B-Lymphocyte / immunology,  metabolism
Antimetabolites, Antineoplastic / pharmacology
Chromosome Aberrations*
Cytogenetic Analysis
DNA Damage
Female
Flow Cytometry / methods*
Fluorouracil / pharmacology
Humans
Male
Mice
Micronucleus Tests
Middle Aged
Neoplasms / blood*,  radiotherapy
Propidium / diagnostic use
Rats
Rats, Sprague-Dawley
Receptors, Transferrin
Reticulocytes / metabolism,  pathology*
Grant Support
ID/Acronym/Agency:
R44ES010752-02/ES/NIEHS NIH HHS; R44ES011244-03/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/Antigens, Differentiation, B-Lymphocyte; 0/Antimetabolites, Antineoplastic; 0/CD71 antigen; 0/Receptors, Transferrin; 36015-30-2/Propidium; 51-21-8/Fluorouracil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Examination of the potential genotoxicity of pure capsaicin in bacterial mutation, chromosome aberra...
Next Document:  Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling...